Evaluation of the association of SNP in carboxylesterase
enzyme (CES1) with pharmacokinetic and adverse effects of
capecitabine in breast and colorectal cancer patients.

dc.contributor.author	Korkmaz, Taner
dc.contributor.author	ÖZTAŞ, Ezgi
dc.contributor.author	Altanlar Türker, Aylin
dc.contributor.author	OKYAR, Alper
dc.contributor.author	PALA KARA, Zeliha
dc.contributor.author	ÖZHAN, Gül
dc.contributor.author	Kurtan Yüksel, Merve
dc.contributor.author	Öztürk, Dilek
dc.date.accessioned	2021-03-02T22:21:54Z
dc.date.available	2021-03-02T22:21:54Z
dc.date.issued	2019
dc.identifier.citation	Kurtan Yüksel M., Öztürk D., ÖZTAŞ E., ÖZHAN G., Altanlar Türker A., Korkmaz T., OKYAR A., PALA KARA Z., "Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients.", ISTANBUL JOURNAL OF PHARMACY, cilt.49, sa.2, ss.64-69, 2019
dc.identifier.other	vv_1032021
dc.identifier.other	av_0c3f0d60-61e9-4279-8e86-2619774cde27
dc.identifier.uri	http://hdl.handle.net/20.500.12627/13884
dc.language.iso	tur
dc.subject	Sağlık Bilimleri
dc.subject	Meslek Bilimleri
dc.subject	Eczacılık
dc.subject	Farmakoloji ve Toksikoloji
dc.subject	Yaşam Bilimleri (LIFE)
dc.title	Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients.
dc.type	Makale
dc.relation.journal	ISTANBUL JOURNAL OF PHARMACY
dc.contributor.department	, ,
dc.identifier.volume	49
dc.identifier.issue	2
dc.identifier.startpage	64
dc.identifier.endpage	69
dc.contributor.firstauthorID	715469

Files in this item

Files	Size	Format	View
There are no files associated with this item.